[Announcement] HGPI Endorsed “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (May 1, 2024)
date : 6/25/2024
Tags: AMR
On May 1, 2024, Health and Global Policy Institute (HGPI) Antimicrobial Resistance (AMR) Team endorsed the policy recommendation “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR).”
Ahead of the UN High-Level Meeting on AMR in September 2024, this recommendation requests the UN members to agree with actionable and measurable steps based on the One Health Approach that considers the interdependence of human health, animal health and environment. The recommendation also highlights the following ten priorities to tackle with AMR.
This recommendation was developed by the AMR Multi-Stakeholder Partnership Platform, in which HGPI participates, co-hosted by the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH).
- Enhance One Health collaboration on AMR through effective cross-sectoral, transparent, inclusive, multilateral, multidisciplinary, multi-stakeholder coordination, communication and follow-through.
- Accelerate the implementation of AMR National Action Plans (NAPs), building on country context, capacity and capabilities.
- Strengthen capacity for AMR efforts by mobilizing sustainable financing for research, infrastructure and AMR NAPs implementation.
- Strengthen health systems through comprehensive primary and secondary prevention strategies, such as infection prevention and control (IPC), stewardship programmes, water, sanitation and hygiene (WASH), vaccination, early diagnosis and prompt treatment and environmental management of air, water, soil, food and vectors for better human, animal and environmental health.
- Better leverage preventive measures such as vaccination by expanding the evidence base on their impact against AMR, developing mechanisms to increase access and utilization of existing vaccines, improving regulatory pathways, facilitating market authorization and distributing products across sectors and countries.
- Strengthen sector-specific AMR and antimicrobial use (AMU) surveillance, building towards integrated surveillance for evidence-based action to reduce the risk and impact of AMR.
- Transform agrifood systems to significantly reduce AMU while optimizing animal health and welfare.
- Ensure universal, equitable, affordable and sustainable access, including in rural areas, to quality essential medicines, vaccines and diagnostics for humans and animals.
- Encourage high-income countries and other stakeholders to commit to taking an end-to-end approach to sustainable antimicrobial research and development (R&D), including by increasing public investment in push and pull incentives to catalyse the global R&D efforts necessary to deliver new treatments and tools that target global priority pathogens.
- Prevent and address the drivers, sources and challenges of the environmental dimensions of AMR.
The AMR Team also provided feedback in finalizing the content of this recommendation.
To read the original recommendation, please click here.
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-24
[Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
-
2026-07-30
[Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)



